Overweight and Obese. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group: In this study, the intervention group consumed 3 scoops of Slimlast powder daily for 12 weeks (a 25-gram serving of Slimlast contains 55 kcal of energy, 10 grams of
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 18 Years
Inclusion criteria
Inclusion criteria: Willingness to cooperate and sign the informed consent form after full knowledge of the objectives and methods of the study. Girls and boys aged 510to 18 years. Having a body mass index Z score higher than 1 and lower than 3 for age and sex Absence of acute or chronic gastrointestinal diseases that may affect the composition of the gut microbiome. No substance abuse, no hormone therapy, no recent weight loss diet. No pregnancy or breastfeeding in women. Do not take medications or supplements that affect appetite, weight, or metabolism for at least 6 months before the study (such as medications that affect carbohydrate, protein, or fat metabolism, and medications that reduce or increase appetite or food intake, including herbal supplements). No history of gastrointestinal surgery. Avoid concomitant use of metabolism-related medications or probiotics, such as antibiotics.
Exclusion criteria
Exclusion criteria: Having any acute illness. The occurrence of any accident that affects a person's health. Acceptance rate less than 80%. Immigration. Exclusion based on personal preference of participants or their parents. Changes in medications taken during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Beginning and end of the study. Method of measurement: scale.;Leptin. Timepoint: Beginning and end of the study. Method of measurement: Laboratory kit.;Serum triglyceride level. Timepoint: Beginning and end of the study. Method of measurement: Laboratory kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Beginning and end of the study. Method of measurement: Calculation.;Serum glucose levels. Timepoint: Beginning and end of the study. Method of measurement: Laboratory kit.;Systolic blood pressure. Timepoint: Beginning and end of the study. Method of measurement: Blood pressure monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTehran University of Medical Sciences
Tehran University of Medical Sciences
Outcome results
None listed